The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension (PAH) treatment Winrevair were so ...

Bristol-Myers Squibb (BMY) stands out as one of the most undervalued biotech stocks, backed by strong financials and a robust drug pipeline. The company has achieved eight consecutive years of ...

Celgene has also filed for approval of the R² regimen for these indolent forms of NHL in Europe and Japan, with an EMA verdict possible before the end of the year. Image Phil Taylor ...

Her leadership background also includes executive roles at Celgene Corporation, where she was President and Chief Operating Officer, among other key positions. Prior to that, she held senior roles at ...

Ulcerative Colitis companies are Janssen Pharmaceuticals, Takeda Pharmaceuticals, Pfizer, EA Pharma, Kissei Pharma, Gilead ...

UK artificial intelligence (AI) drug discovery company Exscientia has agreed a three year drug discovery deal with Celgene, focusing on finding new cancer and autoimmune drugs. Celgene will pay $ ...